TESAMORELIN (5mg-10mg)

Tesamorelin is a synthetic peptide that stimulates the pituitary gland to release growth hormone, primarily used to reduce abdominal fat in HIV patients and for body composition improvement.

What is Tesamorelin
Tesamorelin is a 44-amino acid synthetic peptide that mimics growth hormone-releasing hormone (GHRH), a natural hormone produced by the hypothalamus to signal the pituitary gland to release growth hormone (GH). Unlike direct human growth hormone injections, tesamorelin stimulates your own pituitary gland to produce GH, maintaining the natural feedback loop of the hypothalamic-pituitary axis. This controlled, pulsatile release reduces the risk of disrupting the body’s endocrine balance.
Muscle and Brawn

Mechanism of Action
Tesamorelin binds to GHRH receptors in the anterior pituitary, activating somatotrophic cells to synthesize and secrete GH. The released GH then acts on multiple tissues, including adipocytes (fat cells), myocytes (muscle cells), hepatocytes (liver cells), and osteoblasts (bone cells), promoting fat metabolism, muscle maintenance, and overall anabolic effects. GH also stimulates the liver to produce Insulin-like Growth Factor 1 (IGF-1), which mediates many of tesamorelin’s benefits in body composition and recovery.
Muscle and Brawn

Medical Uses
Tesamorelin is FDA-approved under the brand name Egrifta for reducing excess abdominal fat in HIV-infected adults with lipodystrophy. Clinical trials have shown 15–18% reductions in visceral fat over six months, along with improved lipid profiles and body composition. It is not approved for general weight loss or obesity treatment.

Off-Label and Performance Uses NOT RECOMMENDED ALWAYS CONSULT A PHYSICIAN
Tesamorelin is increasingly used off-label in bodybuilding, anti-aging, and wellness contexts to:
Reduce visceral fat
Enhance lean muscle retention
Boost IGF-1 levels
Support recovery and metabolic health

Safety and Side Effects
Common side effects are generally mild and may include injection site reactions, joint pain, or mild edema. Serious adverse effects are rare but require immediate medical attention. Regular monitoring of blood levels and follow-up with a healthcare provider is recommended to ensure safe use.

Summary
Tesamorelin is a therapeutic GHRH analog that promotes natural GH release, primarily used to reduce abdominal fat in HIV patients but also valued for its effects on body composition and recovery. Its mechanism preserves endocrine balance, making it distinct from direct GH injections, and it is administered via subcutaneous injection under medical supervision.